Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 14, 2025
NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
GlobeNewswire
·
April 14, 2025
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety
GlobeNewswire
·
April 14, 2025
BOCA RATON, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that HiCentral MLS® will offer FOREWARN® services to …
MKS Instruments Announces First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 14, 2025
ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
GlobeNewswire
·
April 14, 2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
GlobeNewswire
·
April 14, 2025
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue- …
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
GlobeNewswire
·
April 14, 2025
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced expected revenue and …
Bitcoin 2.0: BloomBeans Offers $150M Airdrop for a New Economic Foundation
GlobeNewswire
·
April 14, 2025
Lisbon, Portugal, April 14, 2025 (GLOBE NEWSWIRE) -- BloomBeans.io is releasing the first decentraliced financial system to substitute Bitcoin. A New Global Financial System Lead by Takashi Nakamoto and designed by Austrian economists, BloomBeans operates …
NowVertical to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025
GlobeNewswire
·
April 14, 2025
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership …
Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated
GlobeNewswire
·
April 14, 2025
LONDON and AMSTERDAM, April 14, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle computer resources across multiple DePINs (Decentralized Physical Infrastructure Networks), has officially integrated Swarm …
Qorvo® Announces Results of Board Refreshment Process
GlobeNewswire
·
April 14, 2025
Appoints Richard L. Clemmer and Christopher R. Koopmans as Independent Directors David H. Y. Ho to Retire from the Board GREENSBORO, N.C., April 14, 2025 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power …
Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 14, 2025
CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
GlobeNewswire
·
April 14, 2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value Rights …
Avicanna Reports Full Year 2024 Audited Financial Statement
GlobeNewswire
·
April 14, 2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: …
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
GlobeNewswire
·
April 14, 2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that …
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
GlobeNewswire
·
April 14, 2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and …
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
GlobeNewswire
·
April 14, 2025
LEIDEN, Netherlands …
Soleno Therapeutics Announces VYKAT(TM) XR Launch
GlobeNewswire
·
April 14, 2025
REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the U.S. commercial availability of …
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
GlobeNewswire
·
April 14, 2025
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie, 10 Barrel Brewing Co.’s highly-crushable new 5% IPA brewed in partnership with Scout Campers. …
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
GlobeNewswire
·
April 14, 2025
SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that its …